Rep. Josh Gottheimer bought Sarepta Therapeutics (SRPT)
Rep. Josh Gottheimer (D-NJ-5) · $1K–$15K · traded Mar 6, 2023
- Transaction
- Bought
- Amount
- $1K–$15K
- Owner
- Joint
- Traded
- Mar 6, 2023
- Disclosed
- Apr 20, 2023
- Days to disclose
- 45
- Asset type
- Stock
- As filed
- Sarepta Therapeutics, Inc.
- Industry
- Biotechnology · Healthcare
Other trades in this filing
All of Gottheimer's trades →- Apr 20, 2023$1K–$15K
$1K–$15K · Traded Mar 31, 2023 · disclosed Apr 20, 2023 · Joint
- Apr 20, 2023$1K–$15K
$1K–$15K · Traded Mar 31, 2023 · disclosed Apr 20, 2023 · Joint
Got $4K from the company’s PAC - Apr 20, 2023$1K–$15K
$1K–$15K · Traded Mar 31, 2023 · disclosed Apr 20, 2023 · Joint
- Apr 20, 2023$1K–$15K
Sold (partial) Seacoast Banking Corporation of Florida SBCF
$1K–$15K · Traded Mar 29, 2023 · disclosed Apr 20, 2023 · Joint
- Apr 20, 2023$1K–$15K
Sold (partial) Rockwell Automation ROK
$1K–$15K · Traded Mar 27, 2023 · disclosed Apr 20, 2023 · Joint
- Apr 20, 2023$1K–$15K
$1K–$15K · Traded Mar 27, 2023 · disclosed Apr 20, 2023 · Joint
Got $4K from the company’s PAC - Apr 20, 2023$1K–$15K
$1K–$15K · Traded Mar 24, 2023 · disclosed Apr 20, 2023 · Joint
- Apr 20, 2023$1K–$15K
$1K–$15K · Traded Mar 24, 2023 · disclosed Apr 20, 2023 · Joint
Got $4K from the company’s PAC - Apr 20, 2023$1K–$15K
Sold (partial) Deere & Company DE
$1K–$15K · Traded Mar 24, 2023 · disclosed Apr 20, 2023 · Joint
- Apr 20, 2023$1K–$15K
$1K–$15K · Traded Mar 24, 2023 · disclosed Apr 20, 2023 · Joint
- Apr 20, 2023$1K–$15K
$1K–$15K · Traded Mar 23, 2023 · disclosed Apr 20, 2023 · Joint
- Apr 20, 2023$1K–$15K
Bought Blackstone Real Estate Income Trust
$1K–$15K · Traded Mar 22, 2023 · disclosed Apr 20, 2023
- Apr 20, 2023$1K–$15K
Sold (partial) Veritex Holdings VBTX
$1K–$15K · Traded Mar 16, 2023 · disclosed Apr 20, 2023 · Joint
- Apr 20, 2023$1K–$15K
Sold (partial) Thoughtworks Holding TWKS
$1K–$15K · Traded Mar 16, 2023 · disclosed Apr 20, 2023 · Joint
- Apr 20, 2023$1K–$15K
Sold (partial) PayPal Holdings PYPL
$1K–$15K · Traded Mar 16, 2023 · disclosed Apr 20, 2023 · Joint
- Apr 20, 2023$15K–$50K
Sold (partial) Fidelity National Information Services FIS
$15K–$50K · Traded Mar 16, 2023 · disclosed Apr 20, 2023 · Joint
- Apr 20, 2023$1K–$15K
Sold (partial) Crown Castle CCI
$1K–$15K · Traded Mar 16, 2023 · disclosed Apr 20, 2023 · Joint
- Apr 20, 2023$1K–$15K
Sold (partial) ConocoPhillips COP
$1K–$15K · Traded Mar 16, 2023 · disclosed Apr 20, 2023 · Joint
- Apr 20, 2023$1K–$15K
$1K–$15K · Traded Mar 16, 2023 · disclosed Apr 20, 2023 · Joint
- Apr 20, 2023$1K–$15K
$1K–$15K · Traded Mar 15, 2023 · disclosed Apr 20, 2023 · Joint
Recent Congress trades in SRPT
- May 6, 2025$1K–$15K
Rep. Gilbert Ray Cisneros, Jr. (D-CA-31)
Sold Sarepta Therapeutics SRPT
$1K–$15K · Traded Apr 14, 2025 · disclosed May 6, 2025
- Aug 21, 2023$1K–$15K
Rep. Josh Gottheimer (D-NJ-5)
Bought Sarepta Therapeutics SRPT
$1K–$15K · Traded Jul 14, 2023 · disclosed Aug 21, 2023 · Joint
- Jul 11, 2023$1K–$15K
Rep. Josh Gottheimer (D-NJ-5)
Sold Sarepta Therapeutics SRPT
$1K–$15K · Traded Jun 13, 2023 · disclosed Jul 11, 2023 · Joint
- May 19, 2023$15K–$50K
Rep. Daniel S. Goldman (D-NY-10)
Sold Sarepta Therapeutics SRPT
$15K–$50K · Traded Apr 10, 2023 · disclosed May 19, 2023
- Apr 17, 2023$15K–$50K
Rep. Daniel S. Goldman (D-NY-10)
Bought Sarepta Therapeutics SRPT
$15K–$50K · Traded Mar 6, 2023 · disclosed Apr 17, 2023
- Feb 24, 2023$1K–$15K
Rep. Daniel S. Goldman (D-NY-10)
Sold Sarepta Therapeutics SRPT
$1K–$15K · Traded Jan 31, 2023 · disclosed Feb 24, 2023
Company context for SRPT
Recent records for the company. These may have been published before or after this trade; compare the dates before drawing a connection.
SRPT: third_quarter 2026 lobbying report
H.R. 9260 - LHHS Appropriations Rare Pediatric Disease Priority Review Voucher (PRV) Program Issues related to patient access to treatment National Security Commission on emerging biotechnology policy proposals Issues related to Section 232
Public: Oct 19, 2026, 4:58 PM EDTOriginal source ↗SRPT: second_quarter 2026 lobbying report
H.R. 9260 - LHHS Appropriations H.R. 1509 - Accelerating Kids Access to Care Act Patient Access Act Issues related to patient access to treatment National Security Commission on emerging biotechnology policy proposals Issues related to supply chain Issues related to Section 232
Public: Jul 20, 2026, 1:40 PM EDTOriginal source ↗
From a periodic transaction report filed under the STOCK Act. Amounts are the ranges members report. Nothing here is investment advice.